Illumina Inc. (1ILMN)
MTA
Real-time Data
07:00 AM
Day's Range
177.9652 wk Range
77.12Overview - 1ILMN - Illumina Inc.
Key Statistics
Valuation
Enterprise Value
25.14B
P/E (Trailing)
‪39.86‬
PEG Ratio
‪-4.95‬
Price / Sales (TTM)
‪6.13‬
Price / Book
‪11.34‬
EV / EBITDA
‪25.41‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
148.47M
Held by Insiders
‪0.19%‬
Held by Institutions
‪105.90%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪162.73‬
200-Day Avg
‪126.75‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1ILMN - Illumina Inc.
Peers - 1ILMN - Illumina Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on MTA.
- 1ILMNMTAIllumina Inc.19.52BMarket Cap+54.54%52-week change35.44P/E (Trailing)‪18.33%‬Profit Margin
- 1TMOMTAThermo Fisher Scientific Inc.198.93BMarket Cap+22.32%52-week change33.68P/E (Trailing)‪15.03%‬Profit Margin
- 1DHRMTADanaher Corporation147.02BMarket Cap+2.97%52-week change38.55P/E (Trailing)‪15.94%‬Profit Margin
- 1IDXXMTAIDEXX Laboratories, Inc.45.43BMarket Cap-17.43%52-week change41.13P/E (Trailing)‪25.03%‬Profit Margin
- 1LONNMTALonza Group AG41.03BMarket Cap+2.37%52-week change37.50P/E (Trailing)‪-1.60%‬Profit Margin
- 1IQVMTAIqvia Holdings Inc.37.62BMarket Cap+20.59%52-week change129.36P/E (Trailing)‪8.09%‬Profit Margin
- 1AMTAAgilent Technologies Inc.35.81BMarket Cap+24.68%52-week change31.98P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - 1ILMN - Illumina Inc.
About
Illumina, Inc. develops, manufactures, and markets sequencing- and array-based solutions for genetic and genomic analysis worldwide, including in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company provides instruments and consumables such as reagents, flow cells, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
